Could you share your experience with us in which revascularization approach such as DES PCI or CABG is better for which patients?
能否分享在哪些患者适用何种血运重建(如药物支架PCI介入或冠脉搭桥)方面的经验?
Objective Compare drug-eluting stent (DES) to bare-metal stent(BMS) in prognosis on treating diffuse coronary lesions and analysis risk factor of treating complex and diffuse lesions in PCI.
目的比较冠心病患者弥漫病变采用药物洗脱支架和金属裸支架治疗的近期和远期预后,分析影响这类病变介入治疗预后的危险因素。
For specified patients such as left main lesion or muti-vessel lesion, there isn't general agreement in selecting CABG or DES PCI.
对于特定患者如左主干、多支病变时,选择冠脉搭桥还是药物支架pci目前尚存争议。
You know, in China, there are more than 80% ACS patients implanted with DES if they are performed PCI. What do you think about it?
在中国,超过80%急性冠脉综合征的患者介入治疗过程中选择des,您如何看待?
You know, in China, there are more than 80% ACS patients implanted with DES if they are performed PCI. What do you think about it?
在中国,超过80%急性冠脉综合征的患者介入治疗过程中选择des,您如何看待?
应用推荐